Thursday, August 31, 2023

Dept. of Health and Human Services Calls On DEA to Reclassify Cannabis as Schedule III

An official at the Department of Health and Human Services recommended to the Drug Enforcement Agency (DEA) that cannabis be reclassified from a Schedule I drug to a Schedule III drug under the Controlled Substances Act in a leaked letter.

HHS Assistant Secretary for Health Rachel Levine sent a letter dated Aug. 29 to DEA Anne Milgram, recommending that cannabis be reclassified. The HHS confirmed on Tuesday that a representative sent its findings to the DEA. “Following the data and science, HHS has expeditiously responded to President Biden’s directive to HHS Secretary [Xavier Becerra] and provided its scheduling recommendation for marijuana to the DEA on August 29, 2023,” an HHS spokesperson said.

The move was called “historic,” sent cannabis stocks soaring, but was also called insufficient in ending cannabis prohibition as it would remain a controlled substance, albeit with fewer restrictions.

Last October, President Joe Biden requested that the HHS secretary and attorney general conduct a review of the classification of cannabis under federal law. Cannabis currently falls under Schedule I, meaning the DEA considers it a drug “with no currently accepted medical use and a high potential for abuse.”

The DEA defines a Schedule III substance as “drugs with a moderate to low potential for physical and psychological dependence.” The DEA says that the potential for abuse of Schedule III drugs is less than Schedule I and Schedule II drugs—but more habit-forming than Schedule IV (Xanax, Valium) and Schedule V drugs (Robitussin AC). Examples of Schedule III drugs include pills and drugs with less than 90 mg of codeine per dosage unit (Tylenol 3), ketamine, anabolic steroids, and testosterone.

It’s important to note that under Schedule III, cannabis would still be federally prohibited although it would open doors for researchers. Some leaders in Congress applauded the move, while others said it’s not enough.

What Happens Now?

NORML reports that the HHS recommendation now heads to DEA, to conduct its own scientific review. The DEA adopted its own five-factor test to determine if cannabis should be rescheduled, and it’s different from the HHS’ criteria. But the DEA determined that cannabis failed to meet its five criteria four times

“It will be very interesting to see how DEA responds to this recommendation, given the agency’s historic opposition to any potential change in cannabis’ categorization under federal law,” NORML Deputy Director Paul Armentano said. “Further, for decades, the agency has utilized its own five-factor criteria for assessing cannabis’ placement in the CSA—criteria that as recently as 2016, the agency claimed that cannabis failed to meet. Since the agency has final say over any rescheduling decision, it is safe to say that this process still remains far from over.”

Senate Majority Leader Chuck Schumer (D-NY) said in a statement that HHS had recommended that cannabis be moved from a Schedule I to a Schedule III controlled substance. “HHS has done the right thing,” Schumer said. “DEA should now follow through on this important step to greatly reduce the harm caused by draconian marijuana laws.”

Is Schedule III Enough?

“This is a step in the right direction but it is not sufficient, Congressman Earl Blumenauer (D-OR), founder and co-chair of the Congressional Cannabis Caucus said in a statement. “I hope it is followed by more significant reforms. This is long overdue.”

Cannabis coalitions applauded the move as historic, while it would not fully decriminalize cannabis at the federal level.

“The Biden Administration just took a major step toward ending our nation’s failed war on cannabis,” stated Adam Goers, co-chair of the Coalition for Cannabis Scheduling Reform. “For decades, cannabis has been a Schedule I controlled substance, on par with heroin and above fentanyl and meth. This was completely baseless, and we now know that the FDA and Department of Health and Human Services agree.

“The federal government is now on track to recognize cannabis as medicine, regulated alongside Schedule III drugs such as Tylenol with codeine which have demonstrated medical uses and low risk of abuse. Our ultimate goal is full legalization of cannabis, and we believe that rescheduling is a key step on the way there.

Cannabis Stocks Soar

The news impacted cannabis trading. ETF.com reports that the AdvisorShares Pure US Cannabis ETF soared 21%. Other cannabis-related funds, including FMG Alternative Harvest ETF and Global X Cannabis ETF were up 10.79% and 7.44% respectively. Eight cannabis-related ETFs are traded on U.S. markets, with total assets under management of $630.76M. 

Publicly traded cannabis companies also saw spikes based on the news. Canopy Growth rose 13%, Tilray Brands soared by nearly 9%, and Aurora Cannabis rose by 6%.

The post Dept. of Health and Human Services Calls On DEA to Reclassify Cannabis as Schedule III appeared first on High Times.



source https://hightimes.com/news/dept-of-health-and-human-services-calls-on-dea-to-reclassify-cannabis-as-schedule-iii/

Half a Million Fentanyl Pills Disguised as Oxycodone Confiscated by San Bernardino Sheriff’s Office in One Week

Last week was busy for the San Bernardino Sheriff’s Department, who reported Monday that they confiscated over 500,000 fentanyl tablets that were disguised as ”M30” oxycodone pills. One of the primary reasons people overdose on fentanyl is because they think they are taking a less powerful opioid, typically disguised as an oxycodone or hydrocodone pill.

In one bust, a person at a clothing store was allegedly selling a lot more than just clothes: At 10:56 p.m. Friday, police in Hesperia, California served two search warrants at The House of Drip, a clothing store after officers caught wind of a drug operation taking place there. Officers from the San Bernardino Sheriff’s Department suspect that M30 fentanyl pills, as well as cannabis, were being sold at the business.

“Lenin Martinez Arevalo, 29, of Hesperia, was arrested and booked into jail on suspicion of possessing or purchasing drugs for sale, transportation/sales of drugs, and possessing drugs for sale,” the Daily Press in Victorville reports.

Police said they found more than 4,000 fentanyl pills, cannabis, 227 boxes of THC resin, 35 boxes of psilocybin-infused chocolate, and $1,300 in cash while searching the House of Drip.

M30 fentanyl pills are particularly dangerous because they are designed to mimic the look of prescription oxycodone pills, or to a lesser extent—Adderall, Xanax, and other drugs.

A Bigger Problem in San Bernardino County

This was just a fraction of the total number of fentanyl pills the San Bernardino County Sheriff’s Department Gangs/Narcotics Division scooped up last week. They confiscated over half a million fentanyl tablets.

“Last week, the San Bernardino CountySheriff’s Department Gangs/Narcotics Division seized over 115 pounds of fentanyl pills, equivalent to roughly 517,500 tablets. These pills are counterfeit pharmaceuticals containing fentanyl.

Last October, the San Bernardino County Health Department issued a health advisory to spread awareness to the dangers of fentanyl due to a huge uptick in overdose deaths in the county.

In 2021, there were 354 fentanyl overdose deaths in San Bernardino County.

Local health officials launched a campaign to raise awareness due to an unprecedented rise in fentanyl overdoses and poisonings in San Bernardino County. In June, San Bernardino County Department of Behavioral Health officials stated that the campaign will carry out through the year, with the slogan “Fentanyl Doesn’t Care. But We Do.”

“There is a misperception that fentanyl only affects drug addicts when in reality, it’s affecting a broad segment of our community,” Board of Supervisors Chair Dawn Rowe told the Daily Press last summer “This campaign will help shed light on the reality of the fentanyl crisis and help us save lives.”

The health department joined the “Stop the Void and the INTO LIGHT Project” to develop a media campaign targeting geographic areas in San Bernardino County that are prone to a high rate of fentanyl overdoses, with special consideration for young adults and “at-risk underserved communities.”

DEA’s Battle with Fake M30 Pills

San Bernardino County is just one region in California, but the problem stretches across all of the U.S. Data shows that in 2021, nearly 70,000 people in the U.S. died of drug overdoses involving fentanyl and fake opioid prescriptions.

“​​Counterfeit pills are nearly identical to actual prescription medications,” the DEA says in a Drug Fact Sheet. “The majority of counterfeit pills resemble oxycodone 30mg pills (M30s), but can also mimic hydrocodone, alprazolam (Xanax), Adderall, and other medications. There are indications that drug trafficking organizations are specifically targeting kids and teens by creating counterfeit pills in a variety of shapes and bright colors to appeal to that age group. Counterfeit M30 pills can vary in color from white to blue. The best way to avoid counterfeit medication is to take only medications prescribed by a licensed medical professional and dispensed by a registered pharmacist.”

As little as 2 mg of fentanyl can be deadly enough to stop breathing, and death is swift. That means taking just one counterfeit pill can result in death, especially if the person does not have a tolerance. On the other hand, 30 mg of oxycodone is maximum strength, which is strong but less likely to cause death than a smaller amount of fentanyl.

“Distributors in the United States are selling counterfeit pills on social media, appealing to a younger audience that use these apps,” the DEA continues. “Minors and young adults experimenting, as well as regular substance users, believe they are buying authentic oxycodone, Adderall, Xanax, or other medicines, but are unwittingly purchasing counterfeit pills that contain lethal amounts of drugs, usually fentanyl and methamphetamine.”

Fentanyl is around 100 times stronger than morphine, and 50 times stronger than heroin. And how widespread is the problem? Twenty-six percent of tablets tested in a DEA laboratory contained a lethal dose of fentanyl, the agency says. 

The post Half a Million Fentanyl Pills Disguised as Oxycodone Confiscated by San Bernardino Sheriff’s Office in One Week appeared first on High Times.



source https://hightimes.com/news/half-a-million-fentanyl-pills-disguised-as-oxycodone-confiscated-by-san-bernardino-sheriffs-office-in-one-week/

Wednesday, August 30, 2023

New York Supreme Court Judge Lifts Injunction for Small Number of Cannabis Licenses

New York Supreme Court Justice Judge Kevin Bryant recently lifted a temporary injunction that previously halted approval for any state cannabis licenses on Aug. 25. However, only 30 licensees are currently affected by the decision compared to the statewide total of more than 400 applications that are still on hold. 

“As such, those licenses identified by the office of cannabis management will be deemed exempt from the injunction,” Bryant said about his decision.

Those 30 licensees were labeled “ready to open” by both the Cannabis Control Board and the city in which they will operate. According to a PIX11 news report, applicants could potentially become exempt from the injunction if they need their dispensary income to help them financially. “The Judge’s August 18 order outlined certain factors and our job as attorneys representing CAURD licenses is to ensure that our clients are protected and that they fit within an exemption so we need to work to make sure they’re in line with the judge’s order,” said Conditional Adult-Use Retail Dispensary (CAURD) attorney Jorge Luis Vasquez.

In response to Byrant’s most recent decision, the Office of Cannabis Management issued a statement regarding exemptions for those provisional licensees. “While today’s ruling is a disappointment, we are committed to working with the Cannabis Control Board to find a way forward that does not derail our efforts to bring the most equitable cannabis market in the nation to life.”

The lawsuit began on Aug. 2 when a group of military veterans introduced a lawsuit against the Office of Cannabis Management (OCM) and New York Cannabis Control Board, claiming that those agencies did not set up a properly working cannabis industry as stated in the state’s CAURD license, state officials prioritized “justice involved” applicants over disabled veteran applicants.

The Marijuana Regulation and Taxation Act was originally signed in March 2021 by former Gov. Andrew Cuomo, and includes a list of five “social and economic equity” groups that would receive priority for a cannabis license: distressed farmers, individuals who live in areas disproportionately impacted by the War on Drugs, minority-owned businesses, service-disabled veterans, and women-owned businesses.

The lawsuit includes Carmine Fiore (who served eight years in the Army and National Guard), Dominic Spaccio (who spent six years in the U.S. Air Force), William Norgard (a former Army veteran), and Steve Mejia (with six years spent in the Air Force), who are represented by attorneys Brian Thomas Burns, Selbie Lee Jason, and Patrick Joseph Smith, of Clark Smith Villazor.

According to plaintiff Fiore, he and other veterans helped get cannabis legalized, but now are being denied an opportunity to take part in the state’s legal industry and “cast aside for a separate agenda,” Fiore told CBS News.

“From the beginning, our fight has always been for equal access to this new and growing industry,” a joint statement from all four veterans said. “We look forward to working with the state and the court to open the program to all eligible applicants.”

As a result, Judge Bryant issued an injunction on Aug. 7 that prevented the New York Office of Cannabis Management from approving licenses for any new cannabis stores temporarily. In a hearing on Aug. 18, Bryant extended the injunction and said that the CAURD program is in “legal jeopardy,” and predicted that the OCM’s decision not to award licenses to the veteran defendants caused “irreparable harm.”

Clark Smith Villazor released a statement on LinkedIn in response to Bryant’s decision last week. “In a ruling today in favor of Clark Smith Villazor LLP’s four service-disabled veteran clients seeking to enter New York’s nascent retail marijuana industry, a New York State Supreme Court Justice issued a preliminary injunction that largely halts the processing of allegedly unconstitutional conditional adult-use retail dispensary (CAURD) licenses in the cannabis industry,” the firm wrote about the ruling on Aug. 18. “In a 16-page decision, Justice Kevin Bryant found that CSV’s clients ‘presented persuasive and compelling authority’ that the state regulators ‘failed to follow the clear language of the applicable legislation’ by failing to open the retail-dispensary application period to everyone at the same time, including to priority groups like service-disabled veterans.”

Currently, only 23 licensed cannabis stores are open for business in New York, and the decision has halted all progress and is negatively impacting cannabis owners across the state.

Last week, CEO of CONBUD, Coss Marte told High Times how prior to cannabis legalization in New York, 94% of cannabis-related arrests included Black and Latino residents. “We’ve paid our dues. We’ve done the time, and if there’s one thing we hope for the world and the court to know, it’s that like cannabis, we’re here for good and we are here to stay,” Marte said. “We had the opportunity to be heard and to fight on behalf of all of our fellow CAURD licensees who will experience irreparable harm if they’re barred from operating their businesses, and we are confident and hopeful that the court wants a swift resolution that honors the original promises made to justice-impacted license holders.”

The Cannabis Control Board is set to hold a meeting on Sept. 12 to vote on state licensing regulations. “I want this to be as easy as possible, I don’t want to waste unnecessary time,” Bryant said, who also scheduled the next hearing of the case for Sept. 15.

The post New York Supreme Court Judge Lifts Injunction for Small Number of Cannabis Licenses appeared first on High Times.



source https://hightimes.com/news/new-york-supreme-court-judges-lifts-injunction-for-small-number-of-cannabis-licenses/

Tuesday, August 29, 2023

Harlem Set To Open First Legal Dispensary

It is a celebratory time in one of New York City’s most historic neighborhoods, which will open its first legal marijuana dispensary next week. 

The dispensary, known as Gotham Buds, has a “tentative grand opening” scheduled on September 5 at its location just across the street from the iconic Apollo Theater, according to CBS New York.

The local news station noted that the opening of the business has faced “some pushback from the community.”

A Harlem-based business group called the 125th Street Business Improvement District filed a lawsuit in April with the New York Supreme Court, claiming that the “the process was conducted secretly in order to avoid opposition from the community.”

“We’ve taken this action to really create transparency and to create a channel of communication to understand why this location,” Mukaram Taheraly, chairman of the 125th Street Business Improvement District, said at the time, as quoted by CBS New York.

The station explained that it was “the first case challenging the process state regulators use to choose dispensary locations,” and that the lawsuit “accused the state of violating its own law against having a dispensary within 500 feet of a school, with Touro College, which teaches high school students, just a few doors away.”

But in a statement this week ahead of the scheduled opening of Gotham Buds, the 125th Street Business Improvement District hit a more welcoming note.

“We want all of our Harlem businesses to thrive, so we will do everything in our power to help make this be a success for Gotham Buds and our community,” the group said, as quoted by CBS New York.

New York legalized recreational cannabis for adults in 2021, when then-Gov. Andrew Cuomo signed a measure into law. 

Many parts of the law took immediate effect, most notably the provision that enabled those 21 and older to have weed in their possession and to toke up wherever smoking is permitted. 

After Cuomo resigned amid allegations of sexual misconduct in August of that year, he was succeeded by Kathy Hochul, who made it a priority to get the regulated marijuana market up and running.

The state’s first legal marijuana dispensary opened in Manhattan’s East Village neighborhood in December of last year.

“We set a course just nine months ago to start New York’s adult-use cannabis market off on the right foot by prioritizing equity, and now, we’re fulfilling that goal,” Hochul said in a statement at the time. “The industry will continue to grow from here, creating inclusive opportunity in every corner of New York State with revenues directed to our schools and revitalizing communities.”

Under an unprecedented social equity initiative, at least the first 100 dispensary licenses awarded in the Empire State are being awarded to individuals with previous cannabis-related convictions.

“New York State is making history, launching a first-of-its-kind approach to the cannabis industry that takes a major step forward in righting the wrongs of the past,” Hochul said in her announcement of the initiative last year. “The regulations advanced by the Cannabis Control Board today will prioritize local farmers and entrepreneurs, creating jobs and opportunity for communities that have been left out and left behind. I’m proud New York will be a national model for the safe, equitable and inclusive industry we are now building.”

Known as the Seeding Opportunity Initiative, the program “guarantees support for future equity applicants, and secures an early investment into communities most impacted by the disproportionate enforcement of cannabis prohibition,” the governor’s office said at the time.

“Our state’s Cannabis Law sets a high goal for creating an equitable industry that puts New Yorkers first,” Cannabis Control Board Chair Tremaine Wright said in the announcement at the time. “The Seeding Opportunity Initiative puts us on a path for achieving that goal and hopefully models a way forward for reaching those goals while building a stable market. I am thankful for the support of Governor Hochul and the Legislature, which made it possible for us to get this initiative off the ground quickly, establish a supply chain from our farmers to equity, retailers, and generate the resources to help revitalize communities that were harmed by the disproportionate enforcement of cannabis prohibition.” 

The allocation of dispensary licenses has so far been delayed by legal challenges. In a lawsuit filed earlier this month, a group of military veterans challenged the policy of awarding licenses to those with prior convictions. As a result of the lawsuit, a New York judge extended an injunction on the issuing of additional cannabis dispensary licenses until the matter reaches a resolution. 

“That pushes this from being late to the party to potentially exiled from the process,” Brian Burns, an attorney for the plaintiffs, said earlier this month.

“I don’t think you can quantify how being subjected to an unconstitutional program impacts a person,” Burns added.

The post Harlem Set To Open First Legal Dispensary appeared first on High Times.



source https://hightimes.com/news/harlem-set-to-open-first-legal-dispensary/

Researchers Explore Psilocybin’s Antidepressant Effects, How it Disrupts Brain Connectivity

In a recently published preprint study, entitled “Psilocybin desynchronizes brain networks,” researchers analyze the comparison between psilocybin and the default mode network (DMN) of the brain.

“Psilocybin-driven desynchronization was observed across [the] association cortex but strongest in the default mode network (DMN), which is connected to the anterior hippocampus and thought to create our sense of self,” researchers explained.

According to the study, the largest areas of the DMN that were affected by psilocybin in the patients included the thalamus, basal ganglia, cerebellum, and hippocampus. “Persistent suppression of hippocampal-DMN connectivity represents a candidate neuroanatomical and mechanistic correlate for pro-plasticity and anti-depressant effects of psilocybin,” researchers wrote in their abstract.

The study is in the preprint stage of research publication, meaning that it has not yet been peer reviewed, which is required before it can be considered for publication in a research journal. However, using a publication service like medRxiv, research that is not yet peer-reviewed can still be shared and discussed.

However, the team of researchers includes a variety of noteworthy individuals from Washington University School of Medicine, as well as Beth Israel Deaconess Medical Center, Advocate Aurora Health, University of Wisconsin-Madison, and University of California, San Francisco (UCSF). Professor Robin Cahart-Harris of UCSF previously worked on a groundbreaking study that was published last year.

The most recent study analyzed results from seven adults between the ages of 18 and 45, recruited for study between March 2021 to May 2023. Participants were carefully selected with the criteria that they have experienced at least one psychedelic exposure (such as psilocybin, or other substances such as ayahuasca or LSD), but had not had such an experience within the past six months.

Participants were scanned “roughly” every other day in the neuroimaging department at Washington University Medical Center in St. Louis, Missouri. Researchers scanned participants’ brains using precision functional mapping to “identify desynchronization of resting state fMRIs” and find connections to depression-related areas of the brain.

“The relationship between the acute effects of psychedelics and their persisting neurobiological and psychological effects is poorly understood,” researchers explained. “Here, we tracked brain changes with longitudinal precision functional mapping in healthy adults before, during, and for up to three weeks after oral psilocybin and methylphenidate (17 MRI visits per participant) and again six+ months later.”

Methylphenidate is more commonly known as Ritalin and is an FDA-approved stimulant used to treat ADHD and narcolepsy.

These results show that psilocybin “disrupted connectivity across cortical networks and subcortical structures” and produced more noticeable changes than methylphenidate. Additionally, researchers noted that the changes led to brain activity desynchronization of various special scales in the brain.

In April 2022, a collaborative study between the Imperial College London’s Centre for Psychedelic Research and University of California, San Francisco, found that psilocybin helps patients with depression “open up” their brains weeks after consuming. “The effect seen with psilocybin is consistent across two studies, related to people getting better, and was not seen with a conventional antidepressant,” said Carhart-Harris last year. “In previous studies we had seen a similar effect in the brain when people were scanned whilst on a psychedelic, but here we’re seeing it weeks after treatment for depression, which suggests a ‘carry over’ of the acute drug action.”

At the time, Cahart-Harris noted that more research is necessary to better understand how psilocybin affects the brain. “We don’t yet know how long the changes in brain activity seen with psilocybin therapy last and we need to do more research to understand this,” Cahart-Harris said. “We do know that some people relapse, and it may be that after a while their brains revert to the rigid patterns of activity we see in depression.”

Previous psilocybin studies also reveal many other potential benefits of the substance for medical use. In 2015 we saw reports of how psilocybin helped some patients curb alcoholism, and in 2016 another study found that psilocybin could help smokers address nicotine addiction. Most recently, the Imperial College of London is using U.K. government funding this fall to study psilocybin therapy as a way to treat gambling addiction.

Studies analyzing the effects of psilocybin on people with depression have increased over the years, finding correlations between the substance and treatment-resistant depression, major depressive disorder, and more.

The past couple of years have yielded progress in some areas of the U.S. such as Oregon. The state’s psilocybin therapy program laws took effect in January, and its first psilocybin service center was approved in May. “This is such a historic moment as psilocybin services will soon become available in Oregon, and we appreciate the strong commitment to client safety and access as service center doors prepare to open,” said Oregon Psilocybin Services Section Manager Angie Allbee.

This shift in acceptance of psilocybin, like cannabis, has caused an increase in normalcy for people who have tried the substance. Last year, Canadian Senator Larry Campbell spoke at the Catalyst Psychedelics Summit about how he personally uses psilocybin for depression. Former NHL Kyle Quincey, who has shared that he used psilocybin to help boost his mental health during the pandemic, announced in August that he plans to open up a psilocybin retreat called Do Good Ranch.

The post Researchers Explore Psilocybin’s Antidepressant Effects, How it Disrupts Brain Connectivity appeared first on High Times.



source https://hightimes.com/study/researchers-explore-psilocybins-antidepressant-effects-how-it-disrupts-brain-connectivity/

Monday, August 28, 2023

A Crystal Canvas

Alpenglow Extracts, founded by professional snowboarder and cannabis connoisseur, Nathan Lind, is more than just the run-of-the-mill budding cannabis operation—it’s a passion project inspired by the thrill of the slopes, an admiration for the outdoors and, as we hope you might have guessed, copious amounts of weed. Lind credits his company’s appeal to the selective partnerships he’s carved out with leaders in the cultivation sector in Washington state. 

It’s not unusual for pro-athletes to get into marijuana, but it is uncommon for an athlete to heed the cannabis calling while shredding the pow. That’s precisely where Lind experienced his eureka moment. In the early 2000s, while traveling the world competing on the snowboarding circuit (and admittedly smoking a bunch of weed), he found an education in growing cannabis and the extraction process. 

After lots of trial and error, Lind recognized that he had something special to offer the concentrate market, setting out to establish a brand that combined the stoner spirit of his two obsessions: Snowboarding and cannabis. Lo and behold, Alpenglow Extracts was born. The products lend credence to the name Alpenglow, a natural phenomenon of reddish light that occurs in the mountains during sunrise and sunset. Articulating this wonder is impossible unless you’ve seen it for yourself.

“I thought it was a fitting name for a company that celebrates the beauty of nature and the power of cannabis products that also need to be experienced in person to appreciate,” Lind told High Times.

Alpenglow often offers blended offerings, and since these batches are limited drops—maybe 200-300 grams distributed statewide—they never get a second run. Once they’re gone, they’re gone.

Gary’s Cartel THCA, Courtesy Alpenglow Extracts

Gary’s Cartel, THCA Diamond Sauce

It looks like what sank the Titanic, yet it’s likely only sent a slew of Washingtonian dabbers plummeting into cold waters. Gary’s Cartel is a rocks ‘n sauce hybrid combining Weekend at Gary’s and Medellin Jet Fuel Gelato. Part sticky, part liquid (think marmalade), this syrupy diamond-shaped glob is packed with THC, resulting in an intense high dominated by flavors of gas and grape.

Lemon Cherry Terp Dough, Courtesy Alpenglow Extracts

Lemon Cherry Gelato, Live Resin “Terp Dough”

Bakers need dough, and that’s precisely what terp dough is all about. This concentrate consistency is similar to badder, only drier, allowing for more pliability. It’s unique because the extract is literally a dough that can be handled, rolled, and essentially configured at the user’s discretion. Think Play-Doh that can be set on fire. Terp dough is arguably a more diplomatic creation than other dabs. It’s very user friendly, a lot like rosin, melting on the nail like pre-warmed butter.

Rainbow Cuvée, Courtesy Alpenglow Extracts

Rainbow Cuvée, Live Resin

Could it be the pot of gold at the end of the rainbow… or perhaps just a technicolor taste of it? Marvel at this vivid and enticing badder consistency. It’s damp, mushy, almost waxy to the touch with a bright, golden-yellow color that resembles a melting sun dripping down to Earth. This particular extract has been loaded up with terpenes from various representations of Zkittlez, giving it an aroma of sweet and fruity notes, with hints of piney, gassy earthiness. It’s like inhaling a bag of fruit candy, favorable in lemon, lime, and grape.

Cherry Pie, Courtesy Alpenglow Extracts

Cherry Pie, THCA Diamond Sauce

Don’t worry, you won’t need a fork, just a nail. This is another rocks ‘n sauce concoction that, at first glance, appears to be more of a rare gemstone than anything in the realm of cannabis extracts. You can’t go wrong with a classic.

Pink Orangez, Courtesy Alpenglow Extracts

Pink Orangez, Live Resin “Terp Dough”

This is not a shot of a previously undiscovered, alien planet captured by the Webb Telescope. But it might take the user to outer space. No, this is a terp dough infusion that brings together strains Pink Runtz and Black Orange. The Runtz gives it a slap of gas and funk while the Orange delivers a pronounced, well-balanced sweet citrus profile (less rind or sour). Wad up this gorgeous yellow resin anyway you like and let the mandarin orange that dominates the flavor profile bring on the fade. 

THCA Diamonds, Courtesy Alpenglow Extracts

THCA Diamond

A stripped down THCA isolation, this extraction is all rocks; hold the sauce. This concentrate is clear in appearance because all the terpenes have been removed, leaving behind nothing but a bare bones, flavorless high-THC experience (95-98% purity) that can be used to formulate another craft blend. It’s essentially a crystal canvas where a variety of terpenes can be added back into the fold.

This article was originally published in the July 2023 issue of High Times Magazine.

The post A Crystal Canvas appeared first on High Times.



source https://hightimes.com/culture/a-crystal-canvas/

The Summer of Busts

Though the Summer of 2023 has been flush with great musical events, from jam band farewells to EDM gatherings, there has also been the unfortunate reality of drug-related police activity resulting in numerous arrests and large amounts of party favors confiscated. 

Much of this article will be centered around one particular locale where some of the drug busts—along with one tragic mass shooting—took place: the idyllic Gorge Amphitheatre in Grant County, Washington, a legendary venue situated on the banks of the Columbia River in the eastern part of the state. 

The Gorge was the site of the most recent music event spoiled by drug arrests: the Bass Canyon Music Festival, a celebration of EDM (electronic dance music), which took place over the weekend of August 18-20. The Grant Co Sheriff’s Department arrested 13 people while confiscating $20,000 worth of goodies, including cocaine, LSD and ketamine, along with cannabis. Even though weed has been legal in Washington for over a decade, it’s still against the law to sell it without a license.    

The Grant Co Sheriff’s Dept. conducted 14 different investigations in total, their heightened response prompted by an earlier shooting on the same concert grounds in June—more on that story to follow. 

In their official statement to the media, the Sheriff’s Dept. seemed to be rationalizing their overzealous operation, by stating that the concert grounds can hold up to 25,000 people, the same population as nearby small towns.  Yet, modern music festivals have always been about those sorts of cramped conditions, and the vast majority go off smoothly without any overbearing police presence being necessary. 

Similar drug raids were also conducted on the East Coast, including at the Elements Festival in Long Pond, situated in Pennsylvania’s Monroe County. A self-described “car camping” electronic music festival that occurred over the weekend of August 11-14, 11 people in all were arrested, charged with selling various substances to festival attendees.  

According to reports, the increased police scrutiny this year was prompted by overdoses at the Elements Fest the previous year, in 2022. Yet once again, the Sheriff’s Dept’s claims raise the issue that the priority should be ensuring people are offered proper medical services, along with taking safe substances in the first place. Because no matter how big or small of a law enforcement presence there actually is, people are going to take drugs at festivals and concerts, because most of the dealers don’t get caught.

It was an actual shooting—not only overdoses—at the Beyond Wonderland EDM Festival held at the Gorge on Saturday, June 17 that made national headlines. Two people were horrifically shot to death, with two others wounded—including the gunman’s own girlfriend, causing permanent injuries to her. The festival’s Sunday schedule was promptly canceled in wake of the mass shooting.  

It’s worth noting that the two murder victims were a same-sex female couple engaged to be married; they were walking together when Kelly shot them to death. A male who tried to help the victims, as well as the suspect’s aforementioned girlfriend, were wounded by gunfire. The accused gunman, 26-year old James Kelly, who was captured on the festival grounds, is an active-duty soldier stationed in Washington state. It has yet to be revealed whether or not the shootings were politically motivated. Kelly has claimed it was a bad “mushroom trip” that caused him to shoot down his fellow concertgoers, which the corporate media were quick to exploit in their coverage of the shooting. As told to police, during one of the concert performances, a tripping Kelly was filled with thoughts of the world coming to an end, and so he rushed back to his tent, where his gun was waiting to be fired indiscriminately.

The Wonderland incident provided all the justification required for an intricately coordinated multi-agency operation to conduct over-the-top drug activity during the popular jam band Dead and Company’s farewell tour stop to the Gorge on July 7 and 8. 

Mutually involved in the Dead & Co. busts were the Interagency Narcotics Enforcement Team (INET), Grant County Sheriff’s Office, Moses Lake Police Department Street Crimes Unit, as well as Homeland Security Investigations, meaning the US government was involved as well.  

Various substances with a combined estimated street value of over $200,000 were seized, including over 28,000 grams of weed, dabs and edibles, as well as coke, shrooms, molly and acid. In all, 13 people were arrested on drug felony charges.

Posting on their Facebook page July 12, the Grant County Sheriff’s Office issued an official statement regarding the bust, making no apologies for the arrests and seizures:

“The Gorge Amphitheater encourages law enforcement pro-activity at their concerts which are known to have an illegal drug culture based on the number of overdoses and incidents experienced over the years.”  The statement also referenced the recent EDM festival shooting. 

However, the Sheriff’s Dept failed to address the primary problem of the Wonderland incident, which wasn’t the mushrooms, but the firearm that was illegally brought onto the concert grounds, which as stated in the venue’s official rules, is prohibited. While it’s true that psychedelic mushrooms were prohibited too, that substance cannot be used as a weapon to impulsively kill innocent people. Law enforcement did not provide a statement regarding an apparent plan in place to prevent future gun violence at the Gorge, solely focusing on the drugs.

The arrests and seizures at the Gorge were not the first time during the two-month Dead & Co. summer tour that big busts at one of their gigs made the news. When the band performed at the Saratoga Performing Arts Center (aka SPAC), located in upstate New York, on June 17 and 18, local law enforcement was in full force. So full in fact, that the New York State Park Police reported those two D&C shows were among the busiest they’ve ever experienced in terms of drug busts, as well as some actual, violent crime they had to deal with at the venue. The Park Police seized LSD, cocaine, mushrooms, ketamine, meth, weighing equipment and even black-market “packaging”.  Additionally, 54 tanks of nitrous oxide were seized, along with arresting over 30 individuals, as well as confiscating $33,000 in cold hard cash from one luckless drug dealer. 

Concerts by Phish, the biggest jam band outside of Dead & Co., also experienced unwanted—and perhaps unwarranted—treatment by law enforcement. As reported by Phish fans on Reddit, accompanied by photos that provided visual confirmation of the claim, a circulating memo revealed that a federal/local law enforcement joint endeavor was targeting a pair of Phish shows to be held in Burgettstown, Pennsylvania in late July.   

In a memo shared far and wide on the web, the document carried the heading of “Washington County Sheriff’s Office” with an added note “Internal Dissemination Only.” The subject read: “Joint County Task Enforcement Operation ‘Phish in a Barrel’” with the next line indicating the operation was to be conducted at “Star Lake Amphitheatre July 21-22, 2023”, a concert venue outside of Pittsburgh. 

The memo listed the “chain of command” of the various agencies purported to be involved with this operation in hierarchical order, designated by phonetics: “Ops Alpha” was Dept. of Homeland Security, “Ops Bravo” was Washington Co Sheriff’s and “Ops Charlie” was the notorious Drug Enforcement Administration, just to throw an extra scare into any who believed this printed chicanery.  

The memo designated Highway 22 as the “primary checkpoint”, with Highway 18 as the “secondary” checkpoint in which anti-drug units with colorful nicknames like “Team Wolverine” and “Team Badger” would crack down on any would-be partying Phish fans. Perhaps using a code name based on an actual animal-based Phish song such as “Ocelot” or “Possum” might’ve been too obvious. 

Despite the memo seeming quite intentionally comical in hindsight, this document was strongly believed by the Phish and wider jam band communities for a period of time leading up to those concerts. 

So much so that Washington Co Sheriff Tony Andronas felt obligated to post on his Facebook page that “Phish in a Barrel” was indeed a hoax, and in fact, a similar prank had been played on the Virginia State Police in 2018. In that case, as with this most recent one, none of the perpetrators were identified.

Despite the hoax, it turns out the Washington County Sheriff’s Department still made their presence felt in the most unwelcome way at those Phish shows, as officers were actually on the Star Lake “lawn” (the general admission area behind the seats), as visually documented on social media. This time it was no hoax/prank, as photos posted on Reddit revealed the cops were disturbing and disrupting concertgoers’ good times, writing tickets for those merely smoking weed on the lawn. 

With paranoia over the “Phish in a Barrel” hoax being so widespread, in conjunction with all of the excessive actual busts from coast-to-coast, this demonstrates that law enforcement continues to prioritize drug enforcement over public safety at festivals and concerts—so let the attendee beware.

The post The Summer of Busts appeared first on High Times.



source https://hightimes.com/culture/the-summer-of-busts/

Study: Young MJ Consumers With Psychosis Risk Saw Symptom Improvement

A new study, titled “Recreational Cannabis Use Over Time in Individuals at Clinical High Risk for Psychosis: Lack of Associations with Symptom, Neurocognitive, Functioning, and Treatment Patterns” published in the journal Psychiatry Research, examined teens and young adults at risk of developing psychotic disorders. 

Conducted by a team of researchers at Zucker Hillside Hospital, Stanford University School of Medicine, University of Michigan and University of California at Davis, the study found that regular cannabis use over a two-year period did not trigger early onset of symptoms. Rather, the research actually found that it was associated with modest cognitive functioning improvements and reduced use of other medications.

In the study abstract, authors note the varying conclusions in the current body of research surrounding cannabis use and triggering the onset of psychosis among high risk individuals.

“Recreational cannabis use has recently gained considerable interest as an environmental risk factor that triggers the onset of psychosis,” the authors wrote. “To date, however, the evidence that cannabis is associated with negative outcomes in individuals at clinical high risk (CHR) for psychosis is inconsistent.”

To examine the correlation, researchers tracked 210 CHR patients aged 12-25 who participated in an Early Detection and Intervention for the Prevention of Psychosis Program (EDIPPP), with a mean age of 16.54 among the pool. Researchers compared the mental health and prescription usage of those who regularly consumed cannabis to non-users over the two-year period.

Researchers found that cannabis usage was not linked to the onset of psychosis, and they also saw a correlation between cannabis use and positive symptoms when compared to non-users.

Cannabis Use Lacks Psychosis Correlation, May Improve Some Functions

“In summary, continuous cannabis use over 2-years of follow-up was not associated with an increased psychosis transition rate, and did not worsen clinical symptoms, functioning levels, or overall neurocognition. Nevertheless, our findings suggest that continuously using cannabis may be associated with slightly elevated, albeit non-significant, attenuated positive symptom levels relative to non-users,” researchers stated.

“CHR youth who continuously used cannabis had higher neurocognition and social functioning over time, and decreased medication usage, relative to non-users,” they continued. “Surprisingly, clinical symptoms improved over time despite the medication decreases.”

The study was not meant to support cannabis use among youth or cannabis as a therapeutic tool for those at psychosis risk. Rather, it’s meant to add to the growing, and often polarizing, collection of literature on cannabis and psychosis.

A number of recent studies have affirmed the findings of this research. A 2022 study published in the Canadian Journal of Psychiatry analyzed emergency room data related to cannabis-induced psychosis, finding that Canada’s legalization program “was not associated with evidence of significant changes in cannabis-induced psychosis or schizophrenia ED presentations.”

Another study published in January 2023 in the Journal of the American Medical Association considered the same question as it pertains to the United States. Researchers came to the same conclusion: “The findings of this study do not support an association between state policies legalizing cannabis and psychosis-related outcomes.”

An April 2023 study similarly looked to examine the association between cannabis use and psychotic disorders in high-risk patients. They ultimately found, “There was no significant association between any measure of cannabis use at baseline and either transition to psychosis, the persistence of symptoms, or functional outcome.” They added that the findings “contrast with epidemiological data that suggest that cannabis use increases the risk of psychotic disorder.”

A New Version of Old Scare Tactics?

This is in contrast to a number of studies that have claimed cannabis, in fact, is correlated with the onset of psychosis. And opponents of cannabis legalization have claimed that high-THC cannabis can trigger schizophrenia and other extreme mental health symptoms since reform first hit the lips of legislators.

A recent op-ed from NORML’s Paul Armentano suggests that today’s warnings, albeit less sensational, mirror the reefer madness scare tactics of the 1920s and ‘30s, implying that cannabis smoking would lead to “incurable insanity,” among other claims.

“In reality, acute cannabis-induced psychosis is rare, and those who experience it are typically either predisposed to psychosis or have a pre-existing psychiatric disorder,” Armentano writes. He recognizes that those with certain psychiatric disorders may have a greater likelihood of experiencing adverse events after using cannabis, “sensationalizing the potential risks of cannabis will do little to protect them. Calling for the re-criminalization of cannabis in state-legal markets won’t either.”

“Rather, the establishment of a regulated market designed to keep cannabis products away from young people, and that provides clear warnings to those specific populations who may be more vulnerable to its effects—coupled with a policy of consumer education—is the best way to protect public health and mitigate consumers’ risks.”

The post Study: Young MJ Consumers With Psychosis Risk Saw Symptom Improvement appeared first on High Times.



source https://hightimes.com/study/study-young-mj-consumers-with-psychosis-risk-saw-symptom-improvement/

Sunday, August 27, 2023

From the Archives: Who Owns the Sun? (1978)

By Dick Bell

The battle lines over solar power are still being joined, and the struggle is a confusing array of the weak and the powerful, of shifting alliances and contradictory objectives and, most importantly, of the swirling together of two quite distinct revolutions, one technical and the other political.

Is solar simply another energy technology, to be plugged into the existing network of multi-national energy companies? Or will solar provide a wedge that social activists can use to transform society, creating a world in which people control the forces that shape their lives?

There is little doubt that we are going to see a lot of solar, despite the foot dragging of the federal Department of Energy. (DOE has 1,700 people working on nuclear power in 1978 and 38 working on solar.) California has passed a 55-percent tax credit for solar equipment, and Jerry Brown has set a 1985 goal for solar homes in California equal in number to Jimmy Carter’s goal for the whole country by that date.

The real question is no longer whether we’re going to get solar, but what kind of solar it will be and who will control it.

Social theorist Amory Lovins has been the chief prophet of those who see solar as a way of decentralizing the energy business, taking energy out of the hands of the utilities and oil companies.

Lovins’s landmark article in the October 1976 issue of Foreign Affairs, “The Road Not Taken,” laid out the energy future as a choice between two paths. The hard path of nuclear, coal, shale oil and liquefied natural gas is capital intensive, centralized and vulnerable to catastrophic failure. Lovins argued that we could meet our energy needs equally well by using the renewable energy flows from the sun combined with strict energy efficiency techniques.

Solar energy is decentralized to begin with. There are few economies of scale in collecting solar energy, so that many small collectors are just as efficient as a single large one. The dispersion of energy sources also reduces the capital cost and energy losses of centralized distribution systems like today’s electric power grids.

Lovins’s analysis points the way to an energy future in which fossil fuels and nuclear power will disappear as energy sources, replaced by an array of solar technologies: solar heating and cooling, solar thermal, biomass conversion and photovoltaics. These technologies could be deployed on a small scale, so that every community is largely energy independent, subsisting on the energy flows of its region. Utilities would exist, if at all, as a backup system, storing energy and releasing it when needed.

The corporate energy America, industry and however, the rest have of no intention of turning the country over to the small-town, backyard solar pioneers. Responding with the ferocious flexibility for which capitalism is famous, major companies have moved swiftly to bend solar to their way of doing things. GE, Westinghouse, PPG, Owens Illinois, Corning Glass, Libbey-Owens-Ford, Gulf, Royal Dutch Shell, Exxon, Mobil, GM, ITT, Alcoa, Kennecott, Grumman, Martin Marietta, Boeing and Aerospace Corporation are all dabbling in solar, making consumer products and grabbing up patents and DOE research grants.

The oil companies have invested most of their money in photovoltaics, the semiconductors that turn sunlight directly into electricity. Photovoltaic electricity is still far too expensive to compete with current electricity sources. But according to a study done for the Federal Energy Administration last year, the cost would drop dramatically if the government were to place a five-year order for $400 million worth of the devices.

The large purchase would enable manufacturers to automate what is now an extremely labor-intensive process. And as the price began to drop new markets would open up, creating more demand, more automation, still lower prices and yet more demand, until in five years photovoltaics could compete with electricity produced by nuclear or fossil fuels.

Such a development would threaten the utility monopolies, since we could all become rooftop electricity producers, but it would do wonders for oil company profits.

According to a study done by the Center for Science in the Public Interest in Washington, D.C., of the 47 solar patents assigned since the mid 1960s, 30 went to big corporations. A study by the Citizens’ Energy Project of fiscal year 1976 solar contracts showed that large companies received about five times more money than small businesses, $25,070,523 compared to $4,930,338. These same large companies, together with the utilities and the banks, also control the Solar Energy Research Institutes, the regional centers for solar research established by the Energy Research and Development Administration.

The real differences in outlook become even more apparent when one looks at the kinds of projects DOE has been funding. In a series of articles in Science last year, Allen Hammond and William Metz concluded that DOE’s solar research program has emphasized large central stations to produce solar electricity in some distant future and has largely ignored small solar devices for producing on-site power—an approach one critic has described as “creating solar technologies in the image of nuclear power.”

Is this all part of some giant conspiracy to keep solar power out of our hands, or is it just the way monopoly capitalism works?

According to David Morris of the Institute for Local Self-Reliance in Washington, it’s necessary to understand the big-solar mentality. Morris works to promote neighborhood self-sufficiency in food and energy and spends time talking with Washington bureaucrats and politicians. “I go in to one of these energy people and say ‘Small businesses are the most innovative in the country, and they’ll give you the best return for your dollars. Why don’t you fund the small solar pioneers rather than these big companies?’

‘‘They respond, if they’re candid, ‘Look, this small company is going to have to increase in size 10,000 times before it gets to be Sears or GE. If GE wants to go solar, there’ll be solar in every community in the country next year. The big companies have got the franchises, they’ve got the distribution and the factories. We want solar to happen quickly. We don’t want to futz around with small companies, except to the extent they do some good research and development work, in which case they will be bought out by the large companies.’ ”

Lee Johnson of Rain, an alternate technologies magazine, thinks corporations will have a hard time monopolizing solar heating. “I’m not too worried about who’s building flat-plate collectors right now,” Johnson says. “All these big companies with just a few plants on the coast are soon going to find that transportation costs are disadvantageous relative to local production. And these panels are so simple to build. There are so many do-it-yourself plans, and we’ve taught thousands of people how to build them in hands-on workshops. As energy costs continue to rise, local companies will become more competitive, or the big ones will have to decentralize.”

Steve Baer of Zomeworks, the geodesic-dome company, takes Johnson’s analysis one step further. Baer is the inventor of several ingenious and inexpensive solar devices, including the Drumwall, a heating system that uses a wall of recycled 55-gallon drums to collect and store the sun’s heat. “If the big companies are buying up patents, they are probably not buying up very important patents,” Baer says. “There really aren’t many. There’s just nothing in the way of people making good use of the sun. They can’t blame their problems on some patent that’s been purchased by Westinghouse or Dupont.”

Both Johnson and Baer think that the success of passive solar systems will hurt the sales of active collectors. A passive system uses the design and siting of the building to collect, store and circulate heat, without the moving parts of an active system.

“The gadgetry tendency is a misdirection of resources,” Johnson explains. “To build anything that uses active systems totally to heat a house is stupid. Passive systems cost one-half to one-third the price of active systems. The laws have been supporting a ‘solar industry,’ which means an industry making solar panels, when they could have been promoting architects and builders knowing about passive systems.”

But the propaganda for active systems is still growing, and the utilities have begun to smell a way to profit from the enthusiasm for solar. Their proposals are meeting stiff opposition from those who feel the utilities have done enough harm already.

“Monopoly has gotten us where we are, it’s not going to get us out, and it’s not going to help us to further concentrate the means of supplying the energy in their hands,” says David Norris of the Energy Task Force in New York. Norris helped plan the famous East 11th Street project that used sweat equity and government grants to restore a burned-out building, complete with solar hot water and a wind generator on the roof.

“The idea of Con Ed becoming the distributor of a given collector or installers or financiers of solar is a very disturbing one to the low-income communities where service has been so inefficient as well as so costly.”

The alternative proposed by the ETF is a community energy cooperative that would deal with energy issues on a variety of levels, from weather stripping to energy auditing to boiler maintenance and repair. And local energy cooperatives would be part of a federation that would be able to bring to bear some economic impact or to lobby against new Con Ed rate hikes.

Energy activists in California have seized on the idea of a public energy corporation and blown it up to California size in the SolarCal proposal. Sponsored by a coalition of community groups, labor unions and environmentalists, SolarCal calls for the establishment of a multibillion-dollar public energy corporation to promote the solar industry in California, by lending money to consumer and small businesses, carrying out public education campaigns, certifying solar businesses and lobbying for solar energy.

Some alternative energy proponents would like to do away with the electric utility grid, scrapping the network of power lines that link the country’s utilities together. Lee Johnson disagrees. “There was this tendency four or five years ago to become totally energy self-sufficient, to say fuck the rest of the country and go off and farm. But that doesn’t work. Besides, that lets them keep it. That grid is ours. We’re the ratepayers, we’re paying up the ass for all that stuff. We want some say over how it’s used, and the say we want is to be able to put solar and wind electricity back into the grid.”

It’s not at all clear whether people are ready to take over the grid or set up giant public solar utilities. But the enthusiasm for solar is still growing, and even labor unions have begun to recognize the job potential in a full solar program.

This enthusiasm is slowly making itself felt in official Washington, according to David Morris. “For the first time, you have some solar people, either by background or with a philosophical commitment, in DOE at the assistant-secretary level or below. And the Sun Day activities really kick ’em. They just don’t know quite how to respond.

“But it’s the states that really matter, especially California, which they’re scared crap about. Jerry Brown is going to run for the presidency on solar energy. It’s not a coincidence that DOE is talking about setting up an Office of Small Scale Technology or that Energy Secretary Schlesinger is asking what solar is, six months after California passed that 55 percent tax credit.”

Recently, however, Congress has grown increasingly sympathetic to the problems of small solar businesses. Last year’s 9 member solar coalition in Congress has ballooned to more than 60 members this year. When Carter, who said while campaigning that he favored alternate energy technologies and would only use nuclear as a last resort, shocked the solar industry this spring by introducing a budget for the next fiscal year that called for a reduction in the level of solar spending, Congress moved rapidly to increase the budget to more reasonable levels.

The coalition has introduced a wide variety of solar legislation, the most important of which would establish a federal solar fund of $5 billion to make low-cost (3 percent), longterm (up to 30 years) loans for buying solar equipment. Such a fund would give a tremendous boost to solar manufacturers, since commercial and savings banks have been reluctant to lend money for solar projects, much less on such terms.

It is still not clear what path the solar bandwagon will ultimately take. There are those who feel that the dangers of nuclear energy and liquified natural gas are so great that anything that can be done to accelerate the conversion to solar should be done. There is also a growing awareness that translating solar’s potential for decentralization into reality may be a difficult political task.

Read the full issue here.

The post From the Archives: Who Owns the Sun? (1978) appeared first on High Times.



source https://hightimes.com/culture/from-the-archives-who-owns-the-sun-1978/

Saturday, August 26, 2023

‘El Cannabis me Salvó la Vida’: Leroy Rotman Acevedo, el Hijo Prodigio que Adoptó la Marihuana como Inspiración

Nota por Enrique D. Fernández publicada originalmente en El Planteo. Más artículos por El Planteo en High Times en Español.

Síguenos en Instagram (@El.Planteo) y Twitter (@ElPlanteo).

Leroy Rotman Acevedo no sabe quedarse quieto. Además de músico, productor y sonidista, es todo un performer. Se lo puede ver compartiendo escenario junto a sus padres, Sergio Rotman y Midnerely Acevedo (mejor conocida por todos como Mimi Maura), o al frente de Cabezas Parlantes, su banda tributo a Talking Heads.

Claro que semejante pasión se remite a sus orígenes. El joven Leroy se crio entre discos, grabaciones y giras, como si su futuro estuviese predestinado a entregarse por completo a la música.

Su vocación por el sonido era inevitable y, con semejantes padres asegurando una paternidad melómana, nada debería sorprendernos.

Contenido relacionado: 72 años de Joey Ramone, el Dios del Punk que Pidió por la Legalización de la Marihuana

Fan confeso de The Clash, nos dice que ya perdió la cuenta de la cantidad de veces que escuchó el disco Combat Rock. “En casa sonaba de todo. Desde rock progresivo hasta reggae. Ya de grande decidí elegir la rama de producción musical. Hoy produzco más de lo que toco. Me gusta mucho el audio”.

Bajo influencia

A la hora de hablar sobre influencias, se eleva naturalmente su relación con la marihuana. A propósito, confiesa que “el cannabis me salvó la vida”.

¿El motivo? Leroy nos remonta a cuando tenía 18 años y se encontraba pasando por una serie de adicciones que no eran de su agrado.

“Durante las noches me la pasaba frente a la computadora y tomaba bastante alcohol. Al otro día me despertaba sintiéndome pésimo. Pero cuando descubrí el cannabis me sacó por completo de ese lugar. El porro y la música fueron mis mejores elecciones”.

leroy rotman

Asimismo, asegura que a partir de ese momento comenzó a cuestionarse sus inquietudes y se entregó por completo a la cultura del cannabis. Desde entonces, siempre recurre a sus plantas como escape recreativo entre los ensayos y las sesiones de grabación. Claro que las propiedades medicinales de la planta son otra preocupación.

Contenido relacionado: Cómo Inscribirse en REPROCANN Gratis: Guía Paso a Paso para el Registro

“El REPROCANN es el futuro. Escucho historias de gente con Parkinson, con problemas de ansiedad severos, que no puede dormir. Con el aceite cannábico empiezan a encontrar una medicina natural que les sirve. Cualquier persona que hoy en día está en contra del cannabis es alguien a quien no le gusta mucho la humanidad”.

Mamá y papá saben

La pregunta sobre la relaciónentre sus padres y el porro era inevitable. A ellos, por caso, los define como “experimentados en el tema”.

Por lo que ellos me cuentan yo era bastante anti-marihuana. Se escapaban a fumarse un porro y me quejaba del olor. Les decía que no tenían que tomar drogas. Y mi viejo me decía, ‘bueno, vamos a ver cuando tengas 18 años a ver qué opinas’. Al final tenía razón”.

Sobre el tema en cuestión, el mismísimo Rotman opina: “Personalmente pienso que el cannabis es una planta que el ser humano no debería bajo ningún aspecto regentear. Lo mismo legalizar o no algo que no le compete”.

La marihuana se convirtió en un aliado rutinario para Leroy. En especial durante los meses de encierro a los que fue condenado debido a la pandemia. Ese tiempo que pasó junto a sus padres y la música dio como resultado Causalidades, su debut como solista.

Contenido relacionado: Rita Lee: Cómo la Marihuana y el LSD Influenciaron su Carrera Musical y su Vida Personal

Mimi Maura guarda buenos recuerdos de aquel período: “Él había estudiado sonido, así que tenía armado un miniestudio en la casa y la música fue lo que nos sostuvo. Bailando, cantando y escuchando las canciones que Leroy hacía todos los días. Estuvo con distintas ideas que iba puliendo y armando canciones. Eso nos ayudó a alivianar el encierro”.

Cómo viene la mano

Leroy Rotman fue criado en Puerto Rico, de donde Mimi es oriunda. Habiendo pasado buena parte de su juventud allí, el músico cuenta cómo es la situación del cannabis en la sociedad.

En Puerta Rico, la cultura absorbió rápidamente el uso del cannabis. Todos fuman y es completamente legal. Tenés dispensarios y abuelas que comen los ositos de CBD”.

En Argentina, la ley te impulsa a que vos puedas tener tu propia planta. Eso me parece buenísimo. Se están llevando bien los derechos acá”.

Contenido relacionado: EXCLUSIVA: Descubre la Principal Empresa de Cannabis en Puerto Rico, que Ya se Posiciona como Actor Regional

Y sigue: “Todavía veo que cada tanto agarran a pibes teniendo REPROCANN. Eso es algo que con el tiempo y más información va a ir mejorando. Lo estamos transitando. Argentina sigue siendo el país más avanzado culturalmente en cuanto al cannabis de los que conozco”.

Estamos transitando un año de elecciones, ¿cómo ves el panorama en ese sentido?

Hay que ver a quién tenemos ahí arriba. Alguien que se ponga de nuestro lado y nos proteja. Porque así como nos dan este derecho, en el futuro también nos lo pueden sacar. Como tantas otras leyes que en el último tiempo fueron verdes y populares, hay que recordar que todo es una decisión política.

Más contenido de El Planteo:

The post ‘El Cannabis me Salvó la Vida’: Leroy Rotman Acevedo, el Hijo Prodigio que Adoptó la Marihuana como Inspiración appeared first on High Times.



source https://hightimes.com/espanol/el-cannabis-me-salvo-la-vida-leroy-rotman-acevedo-el-hijo-prodigio-que-adopto-la-marihuana-como-inspiracion/